Plasma Nitration of High‐Density and Low‐Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants
Authors:
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2015 (1) , 352356
Abstract
Background. Functional abnormalities of high‐density lipoprotein (HDL) could contribute to cardiovascular disease in chronic kidney disease patients. We measured a validated marker of HDL dysfunction, nitrated apolipoprotein A‐I, in kidney transplant recipients to test the hypothesis that a functioning kidney transplant reduces serum nitrated apoA‐I concentrations. Methods. Concentrations of nitrated apoA‐I and apoB were measured using indirect sandwich ELISA assays on sera collected from each transplant subject before transplantation and at 1, 3, and 12 months after transplantation. Patients were excluded if they have history of diabetes, treatment with lipid‐lowering medications or HIV protease inhibitors, prednisone dose > 15 mg/day, nephrotic range proteinuria, serum creatinine > 1.5 mg/dL, or active inflammatory disease. Sera from 18 transplanted patients were analyzed. Four subjects were excluded due to insufficient data. Twelve and eight patients had creatinine < 1.5 mg/dL at 3 and 12 months after transplantation, respectively. Results. Nitrated apoA‐I was significantly reduced at 12 months after transplantation (p = 0.039). The decrease in apoA‐I nitration was associated with significant reduction in myeloperoxidase (MPO) activity (p = 0.047). In contrast to apoA‐I, nitrated apoB was not affected after kidney transplantation. Conclusions. Patients with well‐functioning grafts had significant reduction in nitrated apoA‐I 12 months after kidney transplantation. Further studies are needed in a large cohort to determine if nitrated apoA‐I can be used as a valuable marker for cardiovascular risk stratification in chronic kidney disease.Keywords
Funding Information
- SUNY/RF Research Collaboration Fund Grant Program (RO1HL095924, HL095924-03S1)
- National Institutes of Health (RO1HL095924, HL095924-03S1)
- NIH Diversity Supplement award (RO1HL095924, HL095924-03S1)
This publication has 57 references indexed in Scilit:
- Biological markers of oxidative stress: Applications to cardiovascular research and practiceRedox Biology, 2013
- Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseAnnals of Internal Medicine, 2012
- Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care databaseBritish Journal of General Practice, 2012
- Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic LesionsJournal of Biological Chemistry, 2012
- High-Density Lipoprotein Cholesterol Efflux, Nitration of Apolipoprotein A-I, and Endothelial Function in Obese WomenThe American Journal of Cardiology, 2012
- Myeloperoxidase in Chronic Kidney DiseaseIndian Journal of Clinical Biochemistry, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- LDL protein nitration: Implication for LDL protein unfoldingArchives of Biochemistry and Biophysics, 2008
- Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitrationFree Radical Biology and Medicine, 2007
- Molecular regulation of HDL metabolism and function: implications for novel therapiesJournal of Clinical Investigation, 2006